Trailing Twelve Months Revenue Growth: Cardiff Oncology, Inc. (CRDF)

Public company logo of Cardiff Oncology Inc. (CRDF)

The implementation of robotic systems for cellular screening accelerates therapy development, impacting the last twelve months (LTM) sales volume trend and daily price action on the GURU.Markets chart for Cardiff Oncology, Inc. (CRDF). The innovative PLK1 inhibitor provides pricing power, while the demand for onvansertib ensures a stable cash generator. The current value of 11.40 determines this specific level of the revenue growth parameter.

Cardiff Oncology (CRDF): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Cardiff Oncology - analytical breakdowns and key metrics (CRDF)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:cardiffoncology.com
Brand item of cardiffoncology.com

For the biotechnology sector, where Cardiff Oncology, Inc. (CRDF) focuses on the development of onvansertib, revenue dynamics serve as an indicator of commercialization and the ability to overcome cancer therapeutic resistance. The year-over-year sales growth percentage for the TTM on the GURU.Markets platform, equal to 11.40, is calculated as the change in total income over the last 12 months relative to the same period last year, reflecting the business's fundamental resilience to market shocks.

Who Cardiff Oncology, Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)